– CANADA, Toronto – FACIT today announced the appointments of Dr. Maura Campbell and Dr. Laszlo Radvanyi to its Board of Directors.
“It is a pleasure to welcome Maura and Laszlo to FACIT’s expanding Board of Directors. We are gaining their invaluable experience as FACIT continues to focus on realizing both economic and patient impact in Ontario. We are also grateful to have benefited from Shana’s academic-entrepreneur perspectives and we wish her much success in her latest endeavours”, said Board Chair, John Morrison.
About Dr. Maura Campbell
Dr. Campbell is currently the President and CEO of Ontario Biosciences Organization (OBIO), a not-for-profit dedicated to advancing health technology innovation and commercialization. She brings to FACIT’s board more than 30 years of experience across both public and private sectors, contributing her deep expertise in technology transfer and commercialization of intellectual property. Dr. Campbell also serves on the Board of Intellectual Property Ontario (IPON) and was appointed to Ontario’s Life Sciences Council (OLSC) along with FACIT President Dr. David O’Neill. Before joining OBIO, Dr. Campbell was the Vice-President of Intellectual Property and Contracts for Turnstone Biologics, a start-up co-founded by FACIT and which recently closed an IPO on the Nasdaq exchange.
About Dr. Laszlo Radvanyi
Dr. Radvanyi is the President and Scientific Director of FACIT’s strategic partner, the Ontario Institute for Cancer Research (OICR), whose overarching mandate is to advance Ontario’s most promising cancer innovations to the benefit of the local economy and patients. His extensive translational cancer research experience includes senior roles spanning academia and industry, at both a multinational pharmaceutical company and a biotechnology startup company.
FACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio has attracted more than $1.5 billion in investment to Ontario. Blending industry experience, capital, and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province’s investment in research and healthcare to benefit of the local economy and patients worldwide.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
